2025-12-03 - Analysis Report
Okay, let's break down the analysis of Salesforce (CRM) based on the information provided.

**1) Return Rate Comparison**

*   **Company Overview:** Salesforce Inc. is a cloud-based software company providing customer relationship management (CRM) services.

*   **Numbers:**
    *   CRM Cumulative Return: -13.15%
    *   S&P 500 (VOO) Cumulative Return: 100.36%
    *   Divergence (CRM - VOO): -113.51%

*   **Analysis:** CRM has significantly underperformed the S&P 500 over the given period, resulting in a large negative divergence. The relative divergence is at the lowest point in the range.

**Alpha, Beta Analysis Table:**

| Year       | CAGR    | MDD  | Alpha  | Beta  | Cap(B) |
|------------|---------|------|--------|-------|--------|
| 2015-2017  | 39.0%   | 70.6%| 10.0%  | -0.0  | 97.7   |
| 2016-2018  | 34.0%   | 73.5%| 19.0%  | 0.1   | 130.9  |
| 2017-2019  | 22.0%   | 73.5%| 0.0%   | 0.4   | 155.5  |
| 2018-2020  | 14.0%   | 73.5%| -10.0% | 0.4   | 212.7  |
| 2019-2021  | 37.0%   | 71.9%| -10.0% | 0.7   | 242.9  |
| 2020-2022  | -78.0%  | 74.7%| -78.0% | 0.4   | 126.8  |
| 2021-2023  | -47.0%  | 76.6%| -49.0% | -0.6  | 251.5  |
| 2022-2024  | -42.0%  | 76.6%| -63.0% | -0.4  | 319.6  |
| 2023-2025  | -2.0%   | 76.6%| -67.0% | -2.1  | 225.0  |

*   **Analysis:**
    *   **CAGR:** The Compounded Average Growth Rate shows strong performance in earlier periods, but significant negative growth in recent years.
    *   **MDD (Maximum Drawdown):** Consistently high, indicating substantial risk. The peak-to-trough decline has remained severe.
    *   **Alpha:** Negative Alpha in recent periods suggests underperformance compared to its benchmark.
    *   **Beta:** Beta values fluctuate, indicating varying sensitivity to market movements. The recent negative Betas mean that the stock has moved inversely to market direction.
    *   **Cap(B):** Market capitalization has generally increased over time, though not always consistently.

**2) Stock Price Fluctuations**

*   **Numbers:**
    *   Current Close: 235.37
    *   Last Market Data: Price: 235.38, Previous Close: 232.83, Change: 1.1
    *   5-day SMA: 231.0
    *   20-day SMA: 238.46
    *   60-day SMA: 243.64

*   **Analysis:**
    *   The current price is slightly above the 5-day SMA, but below the 20-day and 60-day SMAs. This suggests a potential short-term upward trend but potentially facing resistance at the longer-term moving averages. The last market data reflects a recent price increase (1.1).

**3) RSI, PPO, Divergence, and Expected Return**

*   **Numbers:**
    *   Market Risk Indicator (MRI): 0.9 (Medium Investment)
    *   RSI: 44.12
    *   PPO: -0.17
    *   Hybrid Signal: cash_0%_Buy 100% of cash
    *   Recent (20 days) Relative Divergence Change: -1.5 (downward)
    *   Expected Return: -4872.6%

*   **Analysis:**
    *   **MRI:** The Medium Investment recommendation (0.9) indicates that based on the MRI indicator, the investment risk is moderate.
    *   **RSI:** The RSI of 44.12 is close to the oversold threshold (30), suggesting a potential buying opportunity, although not definitively oversold.
    *   **PPO:** The PPO is slightly negative (-0.17), indicating that the short-term moving average is slightly below the long-term moving average.
    *   **Hybrid Signal:** cash_0%_Buy 100% of cash: The hybrid signal suggests buying CRM.
    *   **Recent Relative Divergence Change:** Indicates a short-term decline relative to the comparison index.
    *   **Expected Return:** The significantly negative Expected Return (-4872.6%) is highly concerning and suggests very poor long-term outlook according to the model.

**4) Recent News & Significant Events**

*   **Analysis:** The news headlines present a mixed picture.
    *   Some articles question whether CRM is a buy.
    *   Leadership changes could signal a shift in value.
    *   One article predicts CRM will beat the market in 2026.
    *   Some articles suggest a justified sell-off and opportunity for patient investors.
    *   Analyst upgrades are being watched.
    *   AI fears and earnings are impacting the stock.
    *   **Overall:** The news reflects uncertainty and suggests that investor sentiment is mixed.

**4-2) Analyst Opinions**

*   **Numbers:**
    *   Consensus: Buy
    *   Mean Rating: 1.67 (~Buy)
    *   Opinions: 51
    *   Target Price (avg/high/low): 327.81 / 430.00 / 221.00

*   **Analysis:**
    *   Analysts generally have a "Buy" consensus on CRM, with a significant upside potential based on the average target price. However, the wide range between the high and low target prices indicates uncertainty among analysts.

**5) Recent Earnings Analysis**

| 날짜       | EPS  | 매출     |
|------------|------|----------|
| 2025-09-04 | 1.97 | 10.24 B$ |
| 2025-05-29 | 1.61 | 9.83 B$  |
| 2024-12-04 | 1.60 | 9.44 B$  |
| 2024-08-29 | 1.48 | 9.32 B$  |
| 2025-09-04 | 1.48 | 9.32 B$  |

*   **Analysis:**
    *   EPS and revenue have generally increased over the past few quarters, indicating positive growth.

**6) Financial Information**

Revenue and Profitability:

| Quarter      | Revenue   | Profit Margin |
|--------------|-----------|---------------|
| 2025-07-31   | $10.24B   | 78.10%        |
| 2025-04-30   | $9.83B    | 76.96%        |
| 2025-01-31   | $9.99B    | 77.81%        |
| 2024-10-31   | $9.44B    | 77.71%        |
| 2024-07-31   | $9.32B    | 76.85%        |

Capital and Profitability:

| Quarter      | Equity    | ROE    |
|--------------|-----------|--------|
| 2025-07-31   | $61.33B   | 3.08%  |
| 2025-04-30   | $60.67B   | 2.54%  |
| 2025-01-31   | $61.17B   | 2.79%  |
| 2024-10-31   | $58.52B   | 2.61%  |
| 2024-07-31   | $57.63B   | 2.48%  |

*   **Analysis:**
    *   **Revenue:** Revenue has generally been increasing.
    *   **Profit Margin:** Profit margins are consistently high.
    *   **Equity:** Equity has also generally increased.
    *   **ROE:** ROE has also generally increased.

**7) Comprehensive Analysis (Summary)**

*   **Performance:** CRM has significantly underperformed the S&P 500, with a large negative cumulative return divergence.
*   **Risk:** The high MDD values indicate high risk.
*   **Momentum:** Recent price action shows a slight short-term upward trend, but longer-term moving averages present potential resistance.
*   **Indicators:** RSI is near oversold, and the Hybrid Signal says to buy.
*   **News:** News is mixed, reflecting uncertainty and varying investor sentiment.
*   **Analyst Opinions:** Analysts have a "Buy" consensus, with a high average target price, but also a wide range in target prices.
*   **Financials:** EPS, revenue, profit margin, equity, and ROE have generally increased over the past few quarters.
*   **Expected Return:** The very negative Expected Return is a major red flag and is a large point of concern.

**Conclusion:**

CRM presents a mixed picture. While revenue, earnings, and analyst ratings are generally positive, the stock's underperformance compared to the S&P 500, negative expected return, and recent market performance are causes for concern.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.